Recently, the list of approved projects for the 2025 Shanghai Key Technology R&D Program's “Synthetic Biology” initiative was officially announced, focusing on areas such as nucleic acid synthesis, biomanufacturing, and healthcare.
We use cookies to optimise and personalise your experience, but you can choose to opt out of non-essential cookies.
To find out more, read our Privacy Policy
